ChemMedChem
Scope & Guideline
Pioneering insights for the next generation of pharmaceuticals.
Introduction
Aims and Scopes
- Medicinal Chemistry and Drug Design:
The core focus is on the design, synthesis, and evaluation of new chemical entities with potential therapeutic applications, particularly in oncology, infectious diseases, and metabolic disorders. - Biological Evaluation and Mechanistic Studies:
Research often includes evaluation of biological activities of compounds, exploring mechanisms of action, and understanding structure-activity relationships (SAR) to optimize therapeutic efficacy. - Nanomedicine and Drug Delivery:
The journal publishes studies on novel drug delivery systems, including nanoparticles and nanocarriers, aimed at enhancing the bioavailability and targeted delivery of therapeutic agents. - Natural Products and Synthetic Derivatives:
Research related to the isolation, modification, and pharmacological evaluation of natural products and their synthetic derivatives is a prominent theme, highlighting their potential as drug candidates. - Chemical Biology and Target Identification:
ChemMedChem includes work on the application of chemical tools to elucidate biological pathways, identify drug targets, and develop new therapeutic strategies. - Innovative Analytical Techniques:
The journal encourages the use of advanced analytical techniques such as molecular modeling, high-throughput screening, and various spectroscopic methods to aid drug discovery.
Trending and Emerging
- Targeted Therapy and Precision Medicine:
Recent publications highlight a growing interest in targeted therapies and precision medicine approaches, focusing on personalized treatment options based on genetic and biomolecular profiling. - Proteomics and Targeted Protein Degradation:
The use of proteomics to identify new drug targets and the development of PROTACs (Proteolysis Targeting Chimeras) for targeted protein degradation are gaining traction, showcasing innovative strategies for drug discovery. - Drug Repurposing Strategies:
There is an increasing trend towards drug repurposing, particularly in the context of emerging diseases such as COVID-19, where existing drugs are evaluated for new therapeutic applications. - Nanotechnology in Therapeutics:
The integration of nanotechnology in drug delivery systems, including the use of nanomaterials for enhanced therapeutic efficacy and imaging, is a rapidly expanding area of interest. - Artificial Intelligence and Machine Learning in Drug Discovery:
The application of AI and machine learning techniques for predictive modeling, compound screening, and optimizing drug design processes is becoming increasingly prominent in recent publications. - Hybrid Molecules and Multitarget Agents:
Research on hybrid molecules that combine multiple pharmacophores or target multiple pathways is on the rise, reflecting a shift towards more complex and effective therapeutic agents.
Declining or Waning
- Traditional Small Molecule Antibiotics:
Research on traditional small molecule antibiotics has decreased, possibly due to a shift towards exploring novel mechanisms of action and the use of combination therapies to combat antibiotic resistance. - Single-Target Therapeutics:
The focus on single-target drug design has waned in favor of multitarget approaches, reflecting a growing understanding of the complexity of diseases and the need for holistic treatment strategies. - In vitro Studies without in vivo Validation:
There is a noticeable decline in standalone in vitro studies that lack in vivo validation, as the field increasingly emphasizes translational research that bridges laboratory findings with clinical relevance. - Basic Chemistry without Biological Context:
Papers that focus purely on synthetic methodologies without direct applications in medicinal chemistry or biological evaluation have seen a reduction, as the journal prioritizes research with clear therapeutic implications.
Similar Journals
ACTA PHARMACEUTICA
Fostering collaboration through open-access research excellence.ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.
Future Journal of Pharmaceutical Sciences
Innovating Today for a Healthier TomorrowThe Future Journal of Pharmaceutical Sciences, published by Springer, stands as a vital resource in the realm of pharmaceutical research and innovation. Recognized for its open access initiative since 2015, this journal promotes extensive dissemination of cutting-edge discoveries, fostering collaboration among researchers, industry professionals, and students alike. With an ISSN of 2314-7245 and an E-ISSN of 2314-7253, it aims to bridge the gap between laboratory research and practical applications in the pharmaceutical sciences. Although specific metrics like HIndex and Scopus ranks are currently unavailable, the journal's commitment to high-quality, peer-reviewed content positions it as a promising platform for advancing pharmaceutical science. By engaging with this journal, contributors and readers can participate in the vibrant discourse shaping the future of drug development, therapeutic strategies, and healthcare solutions.
CHEMICAL & PHARMACEUTICAL BULLETIN
Empowering researchers with pivotal findings in drug discovery.CHEMICAL & PHARMACEUTICAL BULLETIN, published by the Pharmaceutical Society of Japan, has been a cornerstone in the fields of chemistry, drug discovery, and medicine since its inception in 1958. With an ISSN of 0009-2363, this esteemed journal offers a platform for the dissemination of innovative research and critical insights contributing to these dynamic disciplines. Housed in Tokyo, Japan, it is strategically poised to bridge the gap between chemical sciences and pharmaceutical applications. Although the journal operates under a traditional subscription model and does not currently offer open access, it maintains a solid reputation, evidenced by its Q3 category rankings in multiple relevant fields and its percentile positions in Scopus, specifically 48th in General Chemistry and 30th in Drug Discovery. Researchers, professionals, and students alike will find invaluable resources within its pages, as it diligently covers shifting paradigms and emerging methodologies critical to advancing both theoretical understanding and practical applications in the pharmaceutical realm.
ARCHIV DER PHARMAZIE
Exploring the Frontiers of Pharmacy ResearchARCHIV DER PHARMAZIE is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to pioneering advances in the fields of Pharmaceutical Science and Drug Discovery. With an impactful history dating back to its inception in 1822, this journal is recognized for its significant contribution to the pharmaceutical sciences, maintaining an impressive Q2 ranking in both the Drug Discovery and Pharmaceutical Science categories as of 2023. The journal’s commitment to excellence is reflected in its Scopus rankings, placing it in the top tiers of relevant fields, ensuring a broad reach and impact among researchers and professionals. Although Open Access options are not available, ARCHIV DER PHARMAZIE continues to be an invaluable resource for scholars seeking to stay abreast of cutting-edge research and developments in pharmacy and related sciences. The journal’s contributions not only serve as crucial benchmarks in research but also enhance the understanding of pharmaceutical innovations, making it essential reading for both seasoned professionals and students alike.
CURRENT DRUG TARGETS
Navigating the Landscape of PharmacologyCURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.
CURRENT MEDICINAL CHEMISTRY
Catalyzing Breakthroughs in Health Sciences.Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.
BIOORGANIC & MEDICINAL CHEMISTRY
Elevating Knowledge in Bioorganic & Medicinal ChemistryBIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.
RSC Medicinal Chemistry
Unlocking the Future of Drug Design and DiscoveryRSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Advancing the frontiers of medicinal chemistry.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
Unlocking Potential with High-Throughput InsightsCOMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING is an esteemed journal published by Bentham Science Publishers Ltd, focusing on the rapidly evolving fields of combinatorial chemistry and high-throughput screening. With ISSN 1386-2073 and E-ISSN 1875-5402, this journal provides a critical platform for researchers, professionals, and students engaged in the development and application of novel methodologies aimed at drug discovery and organic chemistry. Since its inception in 1998, the journal has consistently contributed valuable insights, achieving a respectable 2023 Category Quartile Ranking of Q3 across relevant categories including Computer Science Applications, Drug Discovery, and Organic Chemistry. Although it does not currently provide open access options, its rigorous peer-review process and commitment to scientific excellence enhance its reputation in the academic community. Researchers can leverage this journal's findings to stay at the forefront of advancements in their fields, making it an essential resource for anyone dedicated to innovation in chemistry and related disciplines.